¹®¼­±¤Àå
ÅëÇÕ°Ë»ö
³í¹® > ÀÏ¹Ý³í¹® > ÀÇ/¾àÇÐ (463)
Á¦¸ñ ±¸¸ÅÆò°¡ Çü½Ä °¡°Ý µî·ÏÀÏ
ÀÎõÁö¿ª ´ëÇлýÀÇ ½ÄÀÌŵµ ¹× üÇü¸¸Á·µµ¿Í ºñ¸¸µµ¿ÍÀÇ ºñ±³ Æò°¡¾øÀ½ 700¿ø 2007/03/12
³úÁ¹Áß(Áßdz) ȯÀÚÀÇ ±â´Éȸº¹¿¡ ´ëÇÑ ÃÖ±Ù ¿¬±¸µ¿Çâ °íÂû Æò°¡¾øÀ½ 800¿ø 2007/03/12
°¥±Ù(Ħ) ÃßÃâ¹°ÀÌ Ç×»êÈ­¿¡ ¹ÌÄ¡´Â ¿µÇâ Æò°¡¾øÀ½ 1,500¿ø 2007/03/12
³úÁ¹Áß ¹®Çå°íÂû Æò°¡¾øÀ½ 1,000¿ø 2007/03/12
½Å»ý¾Æ °¨¿°°ü¸® Æò°¡¾øÀ½ 1,300¿ø 2007/03/12
ºÐ¸¸½Ç PIH Àӽżº °íÇ÷¾Ð ÀÚ°£ÀüÁõ ÄÉÀ̽º ½ºÅ͵ð C 1,500¿ø 2007/03/08
¿ì¸® ¼öÇлç¿Í Çö´ë¼öÇÐ Æò°¡¾øÀ½ 2,800¿ø 2007/03/06
½É±Ù°æ»ö F 1,200¿ø 2007/02/26
[¾à¸®ÇÐ] Methotrexate (MTX) Æò°¡¾øÀ½ 700¿ø 2007/02/22
A painful factor Æò°¡¾øÀ½ 1,800¿ø 2007/02/21
Inhibition of Nogo: A key strategy to increase regeneration, Æò°¡¾øÀ½ 1,800¿ø 2007/02/21
Chondroitin sulfate proteoglycans in neural development and Æò°¡¾øÀ½ 1,800¿ø 2007/02/21
¸¸¼º½ÅºÎÀüÄÉÀ̽º Æò°¡¾øÀ½ 1,200¿ø 2007/02/01
´ÙÀÌ¾îÆ®½Ã ¹Ýµå½Ã ¾Ë¾ÆµÎ¾î¾ß ÇÏ´Â °Íµé Æò°¡¾øÀ½ 900¿ø 2007/01/28
ÀúÃâ»ê¹®Á¦ B 800¿ø 2007/01/15